H-Index & Metrics Best Publications

H-Index & Metrics

Discipline name H-index Citations Publications World Ranking National Ranking
Medicine D-index 112 Citations 44,648 408 World Ranking 2274 National Ranking 84

Overview

What is he best known for?

The fields of study he is best known for:

  • Internal medicine
  • Disease
  • Gene

His scientific interests lie mostly in Rheumatoid arthritis, Internal medicine, Arthritis, Immunology and Rheumatology. His research integrates issues of Physical therapy, Connective tissue disease and Disease in his study of Rheumatoid arthritis. The various areas that Gerd R Burmester examines in his Physical therapy study include Alternative medicine, Evidence-based medicine, Family medicine and Intensive care medicine.

His Internal medicine research incorporates themes from Gastroenterology, Placebo and Surgery. His Arthritis research is multidisciplinary, incorporating elements of Porphyromonas gingivalis, Rheumatism and Randomized controlled trial. His Rheumatology research is multidisciplinary, incorporating perspectives in Osteoarthritis, High tibial osteotomy, Chondrocyte and Orthopedic surgery.

His most cited work include:

  • 2010 Rheumatoid arthritis classification criteria: an American College of Rheumatology/European League Against Rheumatism collaborative initiative. (4441 citations)
  • EULAR recommendations for the management of rheumatoid arthritis with synthetic and biological disease-modifying antirheumatic drugs: 2016 update (3425 citations)
  • 2010 rheumatoid arthritis classification criteria: an American College of Rheumatology/European League Against Rheumatism collaborative initiative. (2025 citations)

What are the main themes of his work throughout his whole career to date?

Gerd R Burmester mainly focuses on Internal medicine, Rheumatoid arthritis, Immunology, Rheumatology and Arthritis. His Internal medicine research includes elements of Gastroenterology, Placebo and Surgery. His Surgery study combines topics in areas such as Connective tissue disease and Infliximab.

His Rheumatoid arthritis research is multidisciplinary, incorporating elements of Physical therapy, Clinical trial and Disease. The study incorporates disciplines such as Psoriatic arthritis, Family medicine, Rheumatism, Ankylosing spondylitis and Severity of illness in addition to Rheumatology. His work in Synovitis and Antirheumatic Agents is related to Arthritis.

He most often published in these fields:

  • Internal medicine (53.94%)
  • Rheumatoid arthritis (51.65%)
  • Immunology (31.04%)

What were the highlights of his more recent work (between 2018-2021)?

  • Internal medicine (53.94%)
  • Rheumatoid arthritis (51.65%)
  • In patient (11.20%)

In recent papers he was focusing on the following fields of study:

Gerd R Burmester focuses on Internal medicine, Rheumatoid arthritis, In patient, Sarilumab and Adalimumab. As a part of the same scientific study, Gerd R Burmester usually deals with the Internal medicine, concentrating on Gastroenterology and frequently concerns with Bone remodeling. His studies deal with areas such as Placebo, Methotrexate, Clinical endpoint and Arthritis as well as Rheumatoid arthritis.

His work on Synovitis as part of his general Arthritis study is frequently connected to GERD, thereby bridging the divide between different branches of science. His research in Rheumatology intersects with topics in Medical laboratory, Family medicine and Intensive care medicine. The concepts of his Adverse effect study are interwoven with issues in Oncology, Janus kinase inhibitor, Randomized controlled trial, Myocardial infarction and Filgotinib.

Between 2018 and 2021, his most popular works were:

  • EULAR recommendations for the management of psoriatic arthritis with pharmacological therapies: 2019 update (91 citations)
  • EULAR provisional recommendations for the management of rheumatic and musculoskeletal diseases in the context of SARS-CoV-2. (84 citations)
  • Cardiovascular Safety During Treatment With Baricitinib in Rheumatoid Arthritis. (58 citations)

In his most recent research, the most cited papers focused on:

  • Internal medicine
  • Gene
  • Disease

Internal medicine, Rheumatoid arthritis, Rheumatology, Intensive care medicine and Clinical trial are his primary areas of study. His work is connected to Adalimumab, Adverse effect, Psoriatic arthritis, Tocilizumab and Tofacitinib, as a part of Internal medicine. His studies in Rheumatoid arthritis integrate themes in fields like Methotrexate, Discontinuation, Arthritis, Placebo and Safety profile.

Gerd R Burmester frequently studies issues relating to Family medicine and Rheumatology. His work carried out in the field of Intensive care medicine brings together such families of science as High morbidity, Disease and Interstitial lung disease. In Disease, Gerd R Burmester works on issues like Epidemiology, which are connected to Translational science.

This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.

Best Publications

2010 Rheumatoid arthritis classification criteria: an American College of Rheumatology/European League Against Rheumatism collaborative initiative.

Daniel Aletaha;Tuhina Neogi;Alan J. Silman;Julia Funovits.
Arthritis & Rheumatism (2010)

10141 Citations

EULAR recommendations for the management of rheumatoid arthritis with synthetic and biological disease-modifying antirheumatic drugs: 2016 update

Josef S Smolen;Robert Landewé;Ferdinand C Breedveld;Maya Buch;Maya Buch.
Annals of the Rheumatic Diseases (2014)

3425 Citations

Treating rheumatoid arthritis to target: recommendations of an international task force

Josef S. Smolen;Daniel Aletaha;Johannes W J W Bijlsma;Ferdinand C Breedveld.
Annals of the Rheumatic Diseases (2010)

2471 Citations

Comparison of lumiracoxib with naproxen and ibuprofen in the Therapeutic Arthritis Research and Gastrointestinal Event Trial (TARGET), reduction in ulcer complications: randomised controlled trial.

Thomas J Schnitzer;Gerd R Burmester;Eduardo Mysler;Marc C Hochberg.
The Lancet (2004)

960 Citations

Macrophages in rheumatoid arthritis

Raimund W Kinne;Rolf Bräuer;Bruno Stuhlmüller;Ernesta Palombo-Kinne.
Arthritis Research & Therapy (2000)

905 Citations

Sustained benefits of infliximab therapy for dermatologic and articular manifestations of psoriatic arthritis: results from the infliximab multinational psoriatic arthritis controlled trial (IMPACT).

Christian E. Antoni;Arthur Kavanaugh;Bruce Kirkham;Zuhre Tutuncu.
Arthritis & Rheumatism (2005)

810 Citations

Tofacitinib (CP-690,550) in combination with methotrexate in patients with active rheumatoid arthritis with an inadequate response to tumour necrosis factor inhibitors: a randomised phase 3 trial

Gerd R Burmester;Ricardo Blanco;Christina Charles-Schoeman;Jürgen Wollenhaupt.
The Lancet (2013)

691 Citations

Comparison of lumiracoxib with naproxen and ibuprofen in the Therapeutic Arthritis Research and Gastrointestinal Event Trial (TARGET), cardiovascular outcomes: randomised controlled trial.

Michael E. Farkouh;Howard Kirshner;Robert A. Harrington;Sean Ruland.
The Lancet (2004)

683 Citations

Disturbed peripheral B lymphocyte homeostasis in systemic lupus erythematosus.

Marcus Odendahl;Annett Jacobi;Arne Hansen;Eugen Feist.
Journal of Immunology (2000)

650 Citations

Cardiovascular disease in patients with rheumatoid arthritis: results from the QUEST-RA study

Antonio Naranjo;Tuulikki Sokka;Miguel A. Descalzo;Jaime Calvo-Alén.
Arthritis Research & Therapy (2008)

614 Citations

If you think any of the details on this page are incorrect, let us know.

Contact us

Best Scientists Citing Gerd R. Burmester

Paul Emery

Paul Emery

University of Leeds

Publications: 264

Yoshiya Tanaka

Yoshiya Tanaka

University of Occupational and Environmental Health Japan

Publications: 187

Josef S. Smolen

Josef S. Smolen

Medical University of Vienna

Publications: 155

Paul P. Tak

Paul P. Tak

GlaxoSmithKline (United Kingdom)

Publications: 143

Tsutomu Takeuchi

Tsutomu Takeuchi

Keio University

Publications: 136

Désirée van der Heijde

Désirée van der Heijde

Leiden University Medical Center

Publications: 125

Xavier Mariette

Xavier Mariette

University of Paris-Sud

Publications: 121

Bernard Combe

Bernard Combe

University of Montpellier

Publications: 120

Thomas Dörner

Thomas Dörner

Charité - University Medicine Berlin

Publications: 116

Bruno Fautrel

Bruno Fautrel

Université Paris Cité

Publications: 112

Maxime Dougados

Maxime Dougados

Hôpital Cochin

Publications: 111

Tom W. J. Huizinga

Tom W. J. Huizinga

Leiden University Medical Center

Publications: 110

Iain B. McInnes

Iain B. McInnes

University of Glasgow

Publications: 108

Tore K. Kvien

Tore K. Kvien

University of Oslo

Publications: 101

Daniel Aletaha

Daniel Aletaha

Medical University of Vienna

Publications: 99

Mikkel Østergaard

Mikkel Østergaard

University of Copenhagen

Publications: 97

Something went wrong. Please try again later.